Medicare Part D on the front line

被引：0

作者：

Collins, A ^{[1
]}

机构：

[1] CVS Pharm, Chandler, AZ 85226 USA

来源：

JOURNAL OF MANAGED CARE PHARMACY | 2006年 / 12卷 / 05期

关键词：

D O I：

10.18553/jmcp.2006.12.5.407

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：407 / 408

页数：2

共 50 条

[1] A Physician on the Front Line of Medicare
Bury, John D.
[J]. CANADIAN BULLETIN OF MEDICAL HISTORY, 2009, 26 (02): : 534 - 538
[2] Medicare part D
Sherwin, Robin
[J]. AMERICAN JOURNAL OF NURSING, 2006, 106 (10) : 15 - 15
[3] More on Medicare Part D
Klein, Cathy A.
[J]. NURSE PRACTITIONER, 2007, 32 (05): : 16 - 16
[4] Medicare Part D and decompensation
Park, JM
Hariprasad, R
Park, LT
[J]. PSYCHIATRIC SERVICES, 2006, 57 (05) : 722 - 723
[5] Gabepentinoids and Benzodiazepines in Medicare Part D
Weinhandl, Eric D.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (11): : 2771 - 2771
[6] The Impact and Evolution of Medicare Part D
Donohue, Julie M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08): : 693 - 695
[7] Drug bills and Medicare part D
Rodgers, J
[J]. HEALTH AFFAIRS, 2005, 24 (06) : 1690 - 1690
[8] Formulary committees and Medicare Part D
Sutin, David G.
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (11) : 1790 - 1790
[9] BENEFICIARY CHOICE IN MEDICARE PART D
King, A. J.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A83 - A83
[10] Medicare Part D and Portfolio Choice
Ayyagari, Padmaja
He, Daifeng
[J]. AMERICAN ECONOMIC REVIEW, 2016, 106 (05): : 339 - 342